OpenVSafe by OpenVAERS
Search V-safe

4Q8-12391-63968

2 vaccinations 8 coded responses 18 check-ins 8 free-text entries 5 call cases
Sex
Female
Age at first dose
56-60
ZIP prefix
631 / MO
Registered
2020-12-19
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-18
    Dose 1 — Pfizer-BioNTech
  2. 2020-12-19
    Registered in v-safe
  3. 2020-12-19
    Survey response — days 1–6 daily, dose 1
    MedDRA: Oropharyngeal pain — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Sore throat
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2020-12-19
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to do your normal daily activities
    1 call case(s)
  5. 2020-12-20
    Survey response — days 1–6 daily, dose 1
    MedDRA: Oropharyngeal pain — Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Diarrhea · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Sore theoat
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2020-12-20
    Report sent to call center — days 1–6 daily, dose 1
    Get care from a doctor or other healthcare professional
    1 call case(s)
  7. 2020-12-21
    Survey response — days 1–6 daily, dose 1
    MedDRA: Pharyngitis streptococcal — Feeling: Fair · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Free text: Probable coincidental viral/strep throat infection
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2020-12-21
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to work · Be unable to do your normal daily activities
    1 call case(s)
  9. 2020-12-22
    Survey response — days 1–6 daily, dose 1
    MedDRA: Oropharyngeal pain — Feeling: Fair · Fever · Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Free text: Sore throat
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2020-12-22
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to work · Be unable to do your normal daily activities
    1 call case(s)
  11. 2020-12-27
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  12. 2020-12-29
  13. 2020-12-29
  14. 2020-12-29
  15. 2020-12-29
  16. 2021-01-01
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  17. 2021-01-05
    Dose 2 — Pfizer-BioNTech
  18. 2021-01-05
    Call successful
    Participant prefers to complete VAERS report online
  19. 2021-01-05
    Call successful
    Participant prefers to complete VAERS report online
  20. 2021-01-05
    Call successful
    Does not wish to fill out VAERS report
  21. 2021-01-06
    Call successful
    Participant prefers to complete VAERS report online
  22. 2021-01-09
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Good
    Free text: Right (same side as shot) Axillary lymph node enlargement and significant tenderness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  23. 2021-01-10
    Survey response — days 1–6 daily, dose 2
    MedDRA: Discomfort — Feeling: Good
    Free text: Same axillary discomfort as yesterday, slightly bettr
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  24. 2021-01-11
    Survey response — days 1–6 daily, dose 2
    MedDRA: Axillary pain — Feeling: Good
    Free text: Axillary pain almost gone
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  25. 2021-01-12
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  26. 2021-01-19
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  27. 2021-01-26
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  28. 2021-02-02
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  29. 2021-02-09
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  30. 2021-02-16
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  31. 2021-04-06
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  32. 2021-07-06
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  33. 2022-01-07
    Survey response — 12 months, dose 2
    MedDRA: Basal ganglia stroke, Facial paralysis, Hemiparesis, Speech disorder, Speech rehabilitation — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, Hospitalization
    Free text: Symptoms: Received flu vax 10/4/21, COVID booster 10/6/2021, and Shingles vax (2nd of 2) 10/14/2021. On 11/8/2021, I had a left basal ganglion stroke, with mild right side hemiparesis, facial droop and speech issues. Recovered with very mild residual effects · Healthcare visit (other): Speech tgerapy
    MedDRA releases: 2024-11 · check-in free text available
  34. 2022-01-07
    Report sent to call center — 12 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Emergency room or emergency department visit · Hospitalization · 1 call case(s)
  35. 2022-01-10
  36. 2022-01-13

Vaccinations

DoseDateManufacturerCo-administered
12020-12-18Pfizer-BioNTech
22021-01-05Pfizer-BioNTech

Call center

5 call center cases

4 successful · 1 unsuccessful

See the call center timeline

Free text

Release 1 — days 1–6 daily, dose 1

2020-12-19

Systemic reaction (other): Sore throat

2020-12-20

Systemic reaction (other): Sore theoat

2020-12-21

Systemic reaction (other): Probable coincidental viral/strep throat infection

2020-12-22

Systemic reaction (other): Sore throat

Release 1 — days 1–6 daily, dose 2

2021-01-09

Systemic reaction (other): Right (same side as shot) Axillary lymph node enlargement and significant tenderness

2021-01-10

Systemic reaction (other): Same axillary discomfort as yesterday, slightly bettr

2021-01-11

Systemic reaction (other): Axillary pain almost gone

Release 10 — 12 months, dose 2

2022-01-07

Symptoms: Received flu vax 10/4/21, COVID booster 10/6/2021, and Shingles vax (2nd of 2) 10/14/2021. On 11/8/2021, I had a left basal ganglion stroke, with mild right side hemiparesis, facial droop and speech issues. Recovered with very mild residual effects cut off by CDC
Healthcare visit (other): Speech tgerapy

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOSpeech rehabilitation · · ✓
SDBasal ganglia stroke · · ✓
SDFacial paralysis · · ✓
SDHemiparesis · · ✓
SDSpeech disorder · · ✓
SROAxillary pain ✓ ✓ ✓
SRODiscomfort ✓ ✓ ✓
SROLymph node pain ✓ ✓ ✓
SROLymphadenopathy ✓ ✓ ✓
SROOropharyngeal pain ✓ ✓ ✓
SROPharyngitis streptococcal ✓ ✓ ✓
SROStreptococcal infection ○ ○ ○

✓ active code · ○ coded but marked inactive · blank = not in that release